TXNIP and metabolic dysfunction-associated steatotic liver disease: These findings suggest that TXNIP may be an important mediator of NAFLD, and detailed studies on the molecular mechanism governing control of TXNIP expression may reveal this protein as a potential therapeutic target in NAFLD.